Nursing Institute Schedules Zoom Talks on Research Grants
Published Date: 12/30/2025
Notice
Summary
The National Institute of Nursing Research is holding virtual meetings on January 27 and April 8, 2026, to discuss nursing research updates and review grant applications. These meetings affect researchers and grant applicants, with some sessions open to the public and others closed to protect privacy. No direct money changes are announced, but grant reviews could impact future funding decisions.
Analyzed Economic Effects
2 provisions identified: 1 benefits, 0 costs, 1 mixed.
Open virtual meeting videocast available
You can view the National Advisory Council for Nursing Research open session on January 27, 2026 from 10:00 a.m. to 12:00 p.m. via the NIH Videocast at https://videocast.nih.gov/. Registration is not required to attend the open session.
Closed grant-review session may affect applicants
The Council will hold a closed session on April 8, 2026 from 1:00 p.m. to 2:00 p.m. to review and evaluate grant applications; the session is closed to protect confidential commercial information and personal privacy. These grant reviews could affect future funding decisions for researchers and grant applicants.
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-16683, Proposed Collection; 60-Day Comment Request; Data Use Certification for the NIH National Institute on Drug Abuse Data Share Site
The purpose of this notice is to inform the public of the information collection requirement for the NIDA Data Share, the data use terms and conditions, and to request a progress report statement at the time of renewal. In compliance with the requirement of the Paperwork Reduction Act of 1995 to provide opportunity for public comment on proposed data collection projects, the National Institute on Drug Abuse (NIDA) will publish periodic summaries of proposed projects to be submitted to the Office of Management and Budget (OMB) for review and approval.
2026-16544, Government-Owned Inventions; Availability for Licensing
The inventions listed below are owned by an agency of the U.S. Government and are available for licensing to achieve expeditious commercialization of results of federally-funded research for the benefit of the public health.
2026-16440, NIH Owned Invention Available for License: Soluble Tissue Factor, a Novel Target, and Antibodies, for Diagnosis, Prevention and Treatment of Thrombosis and Related Conditions
Scientists at the National Cancer Institute (NCI) have discovered a novel therapeutic, diagnostic and prognostic target for thrombosis: Soluble Tissue Factor (sTF). NCI has generated first-in- class antibodies and platform selectively neutralizing pathological coagulation while preserving normal hemostasis. This platform technology can be used to prevent, diagnose and treat pathological thrombosis caused by a variety of clinical conditions-including cancer, sepsis, infectious diseases (e.g., COVID), autoimmune disorders, trauma, heart conditions and inflammatory conditions. It offers a much more sensitive and specific test of thrombosis than the current D-dimer test. It may be applicable to any clinical condition which induces necroptosis, pyroptosis and NETtosis, such as cancer, neurodegenerative disease, ischemia-reperfusion and acute injuries, traumatic injuries, bacterial and viral infections, cardiovascular conditions, and atherosclerosis, inflammatory, autoimmune conditions, and others.
2026-16071, Proposed Collection; 60-Day Comment Request: The Impact of Clinical Research Training and Medical Education at the Clinical Center on Physician Careers in Academia and Clinical Research (Clinical Center)
In compliance with the requirement of the Paperwork Reduction Act of 1995, for opportunity for public comment on proposed data collection projects, the Clinical Center, the National Institutes of Health (NIH) will publish periodic summaries of proposed projects to be submitted to the Office of Management and Budget (OMB) for review and approval.
2026-15565, Proposed Collection; 60-Day Comment Request, Data Use Certification for the NIH Brain Development Cohorts (NBDC) Data Hub, (National Institute on Drug Abuse)
In compliance with the requirement of the Paperwork Reduction Act of 1995 to provide opportunity for public comment on proposed data collection projects, the National Institute on Drug Abuse (NIDA) will publish periodic summaries of proposed projects to be submitted to the Office of Management and Budget (OMB) for review and approval. The purpose of this revision is to update instructions for the Research Data Use Statement and the Progress Report, and to add new instructions for attesting to National Institute of Standards & Technology (NIST) security compliance, and for a Project Close-out at the time of project completion. Burden levels remain unchanged.
2026-14966, Government-Owned Inventions; Availability for Licensing
The National Institutes of Health is offering a new Ebola vaccine invention for companies to license and develop quickly. This vaccine targets the Bundibugyo virus and promises fast and lasting protection, helping stop outbreaks in Central Africa. Businesses interested in licensing should act soon to bring this life-saving tech to market and can contact NIH for details.
Previous / Next Documents
Previous: 2025-23975, Combined Notice of Filings #1
The Federal Energy Regulatory Commission got a bunch of new filings from energy companies about power plants, rates, and contracts. These updates affect companies like Chula Vista Energy, National Grid, and Alabama Power, with some changes kicking in as soon as late 2025 or early 2026. If you want to comment or keep an eye on these energy moves, deadlines are mostly in early January 2026.
Next: 2025-23978, Application for Final Commitment for a Long-Term Loan or Financial Guarantee in Excess of $100 Million: AP300117XX-USA
The Export-Import Bank is reviewing a big loan request over $100 million to help U.S. companies keep their factories running and supply chains strong. This loan supports jobs and manufacturing right here at home. If you want to share your thoughts, make sure to comment by January 26, 2026, before the bank’s board makes a final decision.